Reslizumab: Maintenance treatment for eosinophilic asthma inadequately controlled on corticosteroids.
David M. Paton
págs. 323-330
Riboflavin for corneal cross-linking.
D.P.S. O´Brart
págs. 331-346
Cancer Therapeutic Resistance: Progress and Perspectives (April 7-8, 2016 – Barcelona, Spain).
John E. Hutchinson, M.A Pujana, F. J. Arribas Hernández
págs. 347-354
The European League Against Rheumatism (EULAR) – 17th Annual European Congress of Rheumatology (June 8-11, 2016 – London, UK).
Duncan G. Walker, Gary Croasdell
págs. 355-360
American Diabetes Association – 76th Scientific Sessions (June 10-14, 2016 – New Orleans, Louisiana, USA).
Christina S. Lam
págs. 361-366
New product intros
págs. 367-371
© 2001-2024 Fundación Dialnet · Todos los derechos reservados
Coordinado por: